Education
About Us
Working with TipRanks
Follow Us
Teladoc (TDOC)
NYSE:TDOC
TDOC Analyst Ratings
Hold
3 Buy
11 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TDOC Stock 12 Month Forecast
Average Price Target
$9.09
▲(7.19% Upside)
| Highest Price Target$12.00 | Average Price Target$9.09 | Lowest Price Target$7.50 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
$7.5→$8.5
Hold
0.24%
Upside
Reiterated
10/03/25
AI Generated ArticleAI Generated Article
Truist Financial
―
Hold
―
Reiterated
09/26/25
Citi
$9.5
Hold
12.03%
Upside
Reiterated
09/25/25
Teladoc's Transition to Insurance-Based Model and Mixed Growth Signals Lead to Hold RatingWe caught up with TDOC this afternoon to discuss trends heading into the close of 3Q. Below is a summary of our conversation. On the Q2 call, you noted that “softening consumer sentiment” and a “slight uptick in churn rates” were impacting the BetterHelp business. Has this macro trend continued? The cash pay business continues to struggle with high acquisition costs and churn, reinforcing TDOC’s strategic shift to an insurance-based model. The soft launch of the insurance-based offering began in one state in late June. Could you share any initial KPIs or learnings from this launch? It is too early to provide specific KPIs. The biggest gating factor is the timing and credentialing of the provider network. TDOC wants to ensure there is a solid customer experience with therapist capacity and the right payor contracting in place.
Bank of America Securities
$8.5
Hold
0.24%
Upside
Reiterated
09/23/25
Teladoc's Mixed Performance: Hold Rating Amid BetterHelp's Decline and Livongo's GrowthWe remain cautious on the near-term trajectory of BetterHelp, but the recent strength in Chronic Care could partially offset potential weakness. Overall, we see value in TDOCs scaled core network offering with 100MM+ members, but remain cautious on BetterHelp trends and margins in the core business. PO, reflecting 5x CY26E EBITDA.
Stifel Nicolaus
$8
Hold
-5.66%
Downside
Reiterated
07/30/25
Needham
―
Hold
―
Reiterated
07/30/25
Leerink Partners
$7.5
Hold
-11.56%
Downside
Reiterated
07/30/25
TD Cowen
$8
Hold
-5.66%
Downside
Reiterated
07/30/25
Evercore ISI
$7→$8
Hold
-5.66%
Downside
Reiterated
07/30/25
William Blair
―
Hold
―
Reiterated
07/29/25
Cantor Fitzgerald
$12→$10
Buy
17.92%
Upside
Reiterated
07/29/25
Mizuho Securities
$10
Hold
17.92%
Upside
Initiated
07/25/25
Piper Sandler
$12
Buy
41.51%
Upside
Reiterated
07/18/25
J.P. Morgan
$11→$9
Hold
6.13%
Upside
Reiterated
05/16/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
$7.5→$8.5
Hold
0.24%
Upside
Reiterated
10/03/25
AI Generated ArticleAI Generated Article
Truist Financial
―
Hold
―
Reiterated
09/26/25
Citi
$9.5
Hold
12.03%
Upside
Reiterated
09/25/25
Teladoc's Transition to Insurance-Based Model and Mixed Growth Signals Lead to Hold RatingWe caught up with TDOC this afternoon to discuss trends heading into the close of 3Q. Below is a summary of our conversation. On the Q2 call, you noted that “softening consumer sentiment” and a “slight uptick in churn rates” were impacting the BetterHelp business. Has this macro trend continued? The cash pay business continues to struggle with high acquisition costs and churn, reinforcing TDOC’s strategic shift to an insurance-based model. The soft launch of the insurance-based offering began in one state in late June. Could you share any initial KPIs or learnings from this launch? It is too early to provide specific KPIs. The biggest gating factor is the timing and credentialing of the provider network. TDOC wants to ensure there is a solid customer experience with therapist capacity and the right payor contracting in place.
Bank of America Securities
$8.5
Hold
0.24%
Upside
Reiterated
09/23/25
Teladoc's Mixed Performance: Hold Rating Amid BetterHelp's Decline and Livongo's GrowthWe remain cautious on the near-term trajectory of BetterHelp, but the recent strength in Chronic Care could partially offset potential weakness. Overall, we see value in TDOCs scaled core network offering with 100MM+ members, but remain cautious on BetterHelp trends and margins in the core business. PO, reflecting 5x CY26E EBITDA.
Stifel Nicolaus
$8
Hold
-5.66%
Downside
Reiterated
07/30/25
Needham
―
Hold
―
Reiterated
07/30/25
Leerink Partners
$7.5
Hold
-11.56%
Downside
Reiterated
07/30/25
TD Cowen
$8
Hold
-5.66%
Downside
Reiterated
07/30/25
Evercore ISI
$7→$8
Hold
-5.66%
Downside
Reiterated
07/30/25
William Blair
―
Hold
―
Reiterated
07/29/25
Cantor Fitzgerald
$12→$10
Buy
17.92%
Upside
Reiterated
07/29/25
Mizuho Securities
$10
Hold
17.92%
Upside
Initiated
07/25/25
Piper Sandler
$12
Buy
41.51%
Upside
Reiterated
07/18/25
J.P. Morgan
$11→$9
Hold
6.13%
Upside
Reiterated
05/16/25
Best Analysts Covering Teladoc
1 Month
xxx
Success Rate
19/42 ratings generated profit
Average Return
-3.19%
reiterated a xxx
rating 7 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 45.24% of your transactions generating a profit, with an average return of -3.19% per trade.
3 Months
xxx
Success Rate
26/48 ratings generated profit
Average Return
+2.01%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 54.17% of your transactions generating a profit, with an average return of +2.01% per trade.
1 Year
Success Rate
24/48 ratings generated profit
Average Return
+17.97%
reiterated a buy rating 5 months ago
Copying Richard Close's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +17.97% per trade.
2 Years
xxx
Success Rate
21/48 ratings generated profit
Average Return
+47.27%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 43.75% of your transactions generating a profit, with an average return of +47.27% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TDOC Analyst Recommendation Trends
Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
2
0
0
0
0
Buy
0
2
3
3
1
Hold
25
40
27
31
11
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
28
42
30
34
12
Each month's total comprises the sum of three months' worth of ratings.
TDOC Financial Forecast
TDOC Stock Forecast FAQ
What is TDOC’s average 12-month price target, according to analysts?
Based on analyst ratings, Teladoc’s 12-month average price target is 9.09.
What is TDOC’s upside potential, based on the analysts’ average price target?
Teladoc has 7.19% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TDOC a Buy, Sell or Hold?
Teladoc has a consensus rating of Hold which is based on 3 buy ratings, 11 hold ratings and 0 sell ratings.
What is Teladoc’s price target?
The average price target for Teladoc is 9.09. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $12.00 ,the lowest forecast is $7.50. The average price target represents 7.19% Increase from the current price of $8.48.
The highest analyst price target is $12.00 ,the lowest forecast is $7.50. The average price target represents 7.19% Increase from the current price of $8.48.
What do analysts say about Teladoc?
Teladoc’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Streets Analysts.
How can I buy shares of TDOC?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.